The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 11, 2012

Filed:

Nov. 09, 2010
Applicants:

Anthony Murray, Hellerup, DK;

Jesper Lau, Farum, DK;

Lone Jeppesen, Virum, DK;

Per Vedsø, Værløse, DK;

Michael Ankersen, Stenløse, DK;

Jane Marie Lundbeck, Glostrup, DK;

Marit Kristiansen, Søborg, DK;

Maria Carmen Valcarce-lopez, Limhamn, SE;

Dharma Rao Polisetti, High Point, NC (US);

Govindan Subramanian, High Point, NC (US);

Robert Carl Andrews, Jamestown, NC (US);

Daniel P. Christen, Jamestown, NC (US);

Jeremy T. Cooper, Winston-Salem, NC (US);

Kalpathy Chidambareswarak Santhosh, Jamestown, NC (US);

Inventors:

Anthony Murray, Hellerup, DK;

Jesper Lau, Farum, DK;

Lone Jeppesen, Virum, DK;

Per Vedsø, Værløse, DK;

Michael Ankersen, Stenløse, DK;

Jane Marie Lundbeck, Glostrup, DK;

Marit Kristiansen, Søborg, DK;

Maria Carmen Valcarce-Lopez, Limhamn, SE;

Dharma Rao Polisetti, High Point, NC (US);

Govindan Subramanian, High Point, NC (US);

Robert Carl Andrews, Jamestown, NC (US);

Daniel P. Christen, Jamestown, NC (US);

Jeremy T. Cooper, Winston-Salem, NC (US);

Kalpathy Chidambareswarak Santhosh, Jamestown, NC (US);

Assignee:

Novo Nordisk A/S, Bagsvaerd, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/426 (2006.01); A61P 3/10 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 9/12 (2006.01);
U.S. Cl.
CPC ...
Abstract

This invention relates to compounds of formula (I) which are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.


Find Patent Forward Citations

Loading…